The Regulation and Cellular Activities of the ARL2 GTPase
The Regulation and Cellular Activities of the ARL2 GTPase
批准号:
9268023
负责人:
Richard A Kahn
金额:
$30.42万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-01 至 2019-04-30
关键词:
ARL2 geneAddressAffectBindingBiologicalBiologyCell divisionCell physiologyCellsCellular biologyCentrosomeComplexCrista ampullarisCytoskeletonCytosolDimerizationDiseaseDissectionEmbryoEnergy MetabolismEquilibriumEssential GenesEukaryotaEukaryotic CellFamilyFibroblastsFunctional disorderFundingGenerationsGrantGuanosine Triphosphate PhosphohydrolasesHamman-Rich syndromeHealthHeart DiseasesHuman PathologyInterventionKnockout MiceLinkMalignant NeoplasmsMediatingMembraneMembrane Protein TrafficMicrotubulesMitochondriaModelingMolecularMolecular ChaperonesMolecular ModelsMorphologyMusNerve DegenerationOPA1 genePathway interactionsPhenocopyPoint MutationPreparationProcessProductionProteinsReagentRegulationRetinal DegenerationRoleSeriesSignal TransductionSiteSmall Interfering RNASystemTestingTubulinWorkalpha Tubulinbasebeta Tubulincell motilitycofactordeafnessdensitydimerhuman diseaseinsightmembermolecular modelingmutantnovelpolymerizationprotein complexpublic health relevance
中文摘要
描述(由申请人提供):调节性GTP酶ARF家族成员作为细胞信号传导中的节点发挥作用,以协调基本细胞过程;包括膜运输、能量代谢和细胞骨架。本申请的重点是这些GTP酶之一ARL 2及其结合伴侣。了解ARL 2进行或调节基本细胞过程的分子机制将揭示对细胞生物学基本方面的新见解,并为干预提供潜在靶点,以改变人类疾病的进程;包括但不限于癌症,心脏病,神经变性,视网膜变性和耳聋。在过去四年的资助中,我们对真核细胞不同部位的ARL 2作用的几种模型进行了严格的测试,丢弃了一些并改进了另一些。我们还产生了许多关键试剂,包括四种不同蛋白质的mg水平的第一种纯化蛋白质制剂和ARL 2中的一系列点突变,这些点突变允许解剖其在真核细胞中的不同基本作用。因此,我们准备在微管蛋白折叠和聚合、线粒体中ATP产生以及线粒体分裂和运动调节的分子机制的理解方面取得更快的进展。在下一个资助期内,我们提出了三个新的具体目标,这些目标是我们以前工作的逻辑延伸,但有望对细胞信号传导和调控的几个领域产生更广泛的影响。在aim 1中,我们将测试
ARL 2与微管蛋白特异性辅助分子伴侣辅因子D(TBCD)共同作用调节微管蛋白折叠、微管密度或聚合以及较少直接的细胞分裂的模型。在目标2中,我们将测试ARL 2通过嵴重塑和线粒体融合的变化来调节线粒体中ATP产生的假设。在目标3中,我们研究了ARL 2效应子和GAP,ELMOD 2如何调节线粒体融合和运动。
英文摘要
DESCRIPTION (provided by applicant): Members of the ARF family of regulatory GTPases function as nodes in cell signaling to coordinate essential cell processes; including membrane traffic, energy metabolism, and the cytoskeleton. The focus of this application is one of those GTPases, ARL2, and its binding partners. An understanding of the molecular mechanisms of ARL2 action to carry out or regulate essential cell processes will reveal novel insights into fundamental aspects of cell biology as well as providing potential targets for intervention to alte the course of human diseases; including but not limited to cancer, heart disease, neurodegeneration, retinal degeneration, and deafness. During the previous four years of funding we have provided rigorous tests of several models for ARL2 actions in different parts of eukaryotic cells, discarding some and refining others. We have also generated many key reagents, including the first purified protein preparations of mg levels of four different proteins and a series of point mutations in ARL2 that allow dissection of its different essential roles in eukaryotic cells. Thus, we are poised to make much more rapid progress in our understanding of the molecular mechanisms of regulation of tubulin folding and polymerization, ATP generation in mitochondria, and mitochondrial fission and motility. In the next funding period we propose three new, specific aims that are logical extensions of our previous work but which promise to have a far broader impact on several fields of cell signaling and regulation. In aim 1 we will test
the model that ARL2 acts with the tubulin-specific co-chaperone cofactor D (TBCD) to regulate tubulin folding, microtubule density or polymerization, and less directly cell division. In aim 2 w will test the hypothesis that ARL2 regulates ATP production in mitochondria via changes in cristae remodeling and mitochondrial fusion. And in aim 3 we examine how mitochondrial fusion and motility are regulated by the ARL2 effector and GAP, ELMOD2.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Is the model of signal amplification by GPCRs/GEFs activating multiple GTPases relevant to a broad spectrum of heterotrimeric and RAS superfamily GTPases?
GPCR/GEF 激活多个 GTP 酶的信号放大模型是否与广谱异源三聚体和 RAS 超家族 GTP 酶相关?
DOI:
10.4161/21592780.2014.943602
发表时间:
2014
期刊:
Cellular logistics
影响因子:
--
作者:
[Kahn,RichardA]
通讯作者:
Kahn,RichardA
DOI:
10.4161/cl.1.2.15153
发表时间:
2011-03
期刊:
Cellular logistics
影响因子:
--
作者:
[R. Kahn]
通讯作者:
R. Kahn
DOI:
10.1007/978-1-4939-2425-7_28
发表时间:
2015
期刊:
Methods in molecular biology (Clifton, N.J.)
影响因子:
--
作者:
[Bennett,MatthewA, Shern,JackF, Kahn,RichardA]
通讯作者:
Kahn,RichardA
DOI:
10.1080/21592799.2015.1090523
发表时间:
2015-07
期刊:
Cellular logistics
影响因子:
--
作者:
[Kerr SC, Kahn RA]
通讯作者:
Kahn RA
Production of antisera using fusion proteins.
使用融合蛋白生产抗血清。
DOI:
10.1002/0471142301.ns0507s40
发表时间:
2007
期刊:
Current protocols in neuroscience
影响因子:
--
作者:
[Dodson,SaraE, Heilman,CraigJ, Kahn,RichardA, Levey,AllanI]
通讯作者:
Levey,AllanI
共 7 条
Molecular mechanisms of ARF family GTPases
-
批准号:10001990
-
项目类别:
-
资助金额:$49.01万
-
财政年份:2017
-
负责人:Richard A Kahn
-
依托单位:
Molecular mechanisms of ARF family GTPases
-
批准号:9893466
-
项目类别:
-
资助金额:$9.54万
-
财政年份:2017
-
负责人:Richard A Kahn
-
依托单位:
Molecular mechanisms of ARF family GTPases
-
批准号:10330783
-
项目类别:
-
资助金额:$57.21万
-
财政年份:2017
-
负责人:Richard A Kahn
-
依托单位:
Molecular mechanisms of ARF family GTPases
-
批准号:10675436
-
项目类别:
-
资助金额:$50.99万
-
财政年份:2017
-
负责人:Richard A Kahn
-
依托单位:
Molecular mechanisms of ARF family GTPases
-
批准号:10247516
-
项目类别:
-
资助金额:$49.01万
-
财政年份:2017
-
负责人:Richard A Kahn
-
依托单位:
The Regulation and Cellular Activities of the ARL2 GTPase
-
批准号:8964313
-
项目类别:
-
资助金额:$32.84万
-
财政年份:2010
-
负责人:Richard A Kahn
-
依托单位:
The regulation and cellular activities of the Arl2 GTPase
-
批准号:8330939
-
项目类别:
-
资助金额:$48.45万
-
财政年份:2010
-
负责人:Richard A Kahn
-
依托单位:
The regulation and cellular activities of the Arl2 GTPase
-
批准号:8508271
-
项目类别:
-
资助金额:$45.6万
-
财政年份:2010
-
负责人:Richard A Kahn
-
依托单位:
The regulation and cellular activities of the Arl2 GTPase
-
批准号:7987019
-
项目类别:
-
资助金额:$29.14万
-
财政年份:2010
-
负责人:Richard A Kahn
-
依托单位:
The regulation and cellular activities of the Arl2 GTPase
-
批准号:8460228
-
项目类别:
-
资助金额:$6.16万
-
财政年份:2010
-
负责人:Richard A Kahn
-
依托单位:
The regulation and cellular activities of the Arl2 GTPase
-
批准号:8136656
-
项目类别:
-
资助金额:$28.85万
-
财政年份:2010
-
负责人:Richard A Kahn
-
依托单位:
ARL2: Regulator of Cytoskeleton and Mitochondria
-
批准号:7162622
-
项目类别:
-
资助金额:$25.46万
-
财政年份:2004
-
负责人:Richard A Kahn
-
依托单位:
ARL2: Regulator of Cytoskeleton and Mitochondria
-
批准号:7001332
-
项目类别:
-
资助金额:$26.22万
-
财政年份:2004
-
负责人:Richard A Kahn
-
依托单位:
ARL2: Regulator of Cytoskeleton and Mitochondria
-
批准号:6720768
-
项目类别:
-
资助金额:$26.85万
-
财政年份:2004
-
负责人:Richard A Kahn
-
依托单位:
ARL2: Regulator of Cytoskeleton and Mitochondria
-
批准号:6841667
-
项目类别:
-
资助金额:$26.85万
-
财政年份:2004
-
负责人:Richard A Kahn
-
依托单位:
Regulation of vesicular membrane traffic by ARF proteins
-
批准号:6751206
-
项目类别:
-
资助金额:$27.36万
-
财政年份:2003
-
负责人:Richard A Kahn
-
依托单位:
Regulation of vesicular membrane traffic by ARF proteins
-
批准号:7072311
-
项目类别:
-
资助金额:$26.72万
-
财政年份:2003
-
负责人:Richard A Kahn
-
依托单位:
Regulation of vesicular membrane traffic by ARF proteins
-
批准号:6569592
-
项目类别:
-
资助金额:$29.42万
-
财政年份:2003
-
负责人:Richard A Kahn
-
依托单位:
Regulation of post-Golgi traffic by Arf and Arf-dependent adaptors
-
批准号:7628534
-
项目类别:
-
资助金额:$31.0万
-
财政年份:2003
-
负责人:Richard A Kahn
-
依托单位:
Regulation of post-Golgi traffic by Arf and Arf-dependent adaptors
-
批准号:8080420
-
项目类别:
-
资助金额:$30.38万
-
财政年份:2003
-
负责人:Richard A Kahn
-
依托单位:
海外基金